Stock Value
Competitors
| Ticker | Price | Forecast 1Y | Forecast 2Y | Market Cap | Div Yld | Growth Rate |
|---|---|---|---|---|---|---|
|
NasdaqGM:GWPH
GW Pharmaceuticals
|
219.00 | 0% | 0% | 6,907.02 | 0% | 0% |
|
NasdaqGS:ABCM
Abcam
|
23.99 | 0% | 0% | 5,519.95 | 0% | 0% |
|
LSE:GNS
Genus
|
18.92 | 70.49% | 107.84% | 1,182.76 | 1.7% | 2.29% |
|
NasdaqGS:AUTL
Autolus Therapeutics
|
4.17 | 0% | 0% | 1,114.23 | 0% | 0% |
|
NasdaqGS:BCYC
Bicycle Therapeutics
|
23.58 | 0% | 0% | 1,048.91 | 0% | 0% |
|
NasdaqGM:SLN
Silence Therapeutics
|
22.95 | 0% | 0% | 1,019.01 | 0% | 0% |
|
NasdaqGS:CMPS
COMPASS Pathways
|
8.54 | 0% | 0% | 582.96 | 0% | 0% |
|
NasdaqCM:MREO
Mereo BioPharma Group
|
3.27 | 0% | 0% | 427.07 | 0% | -,400% |
|
NasdaqCM:ORTX
Orchard Therapeutics
|
16.70 | 0% | 0% | 380.12 | 0% | 0% |
|
AIM:NIOX
NIOX Group Plc
|
0.72 | -86.95% | -82.55% | 301.02 | 1.38% | 200% |
|
LSE:OXB
Oxford Biomedica
|
3.20 | -,312.49% | -,233.74% | 276.5 | 0% | 0% |
|
NasdaqGS:ADAP
Adaptimmune Therapeutics
|
1.14 | 0% | 0% | 304.12 | 0% | 0% |
|
AIM:BVXP
Bioventix PLC
|
43.50 | -16.85% | -6.66% | 223.14 | 3.53% | 9.21% |
|
AIM:HZD
Horizon Discovery Group
|
0.00 | 0% | 0% | 161.93 | 0% | 0% |
|
AIM:ETX
e-therapeutics
|
0.16 | 0% | 0% | 133.27 | 0% | 0% |
|
AIM:AGY
Allergy Therapeutics
|
0.03 | 0% | 0% | 119.16 | 0% | 0% |
|
AIM:SCLP
Scancell Holdings
|
0.10 | 0% | 0% | 79.52 | 0% | 0% |
|
NasdaqGM:BRNS
Barinthus Biotherapeutics
|
2.35 | 0% | 0% | 97.69 | 0% | 0% |
|
AIM:REDX
Redx Pharma Plc
|
0.17 | 0% | 0% | 71.96 | 0% | 0% |
|
AIM:DDDD
4D pharma
|
0.36 | 0% | 0% | 71.04 | 0% | 0% |
